Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| D1 Capital Partners L.P. | CART Maplebear Inc. | 13G | 13.5% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | EOLS Evolus, Inc. | 13G | 5.1% | Dec 31, 2023 | 2y |
| HHLR ADVISORS, LTD. | MOGU MOGU Inc. | 13G/A | 11.8% | Dec 31, 2023 | 2y |
| Jessica Warren | HNST Honest Company, Inc. | 13G | 6.5% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | HCP HashiCorp, Inc. Class A Common Stock | 13G/A | 0.7% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | CHUY Chuy's Holdings, Inc. Common Stock | 13G/A | 11.1% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | XGN Exagen Inc. | 13G/A | 8.8% | Dec 31, 2023 | 2y |
| Fairmount Funds Management LLC | TERN Terns Pharmaceuticals, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Greenvale Capital LLP | CARS Cars.com Inc. | 13G/A | 7% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | TECX Tectonic Therapeutic, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | AZR Azora Therapeutics, Inc. (DE) | 13G | 9.99% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | RMR Rmr Group Inc. | 13G/A | 2.6% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | FATP Fat Projects Acquisition Corp Class A Ordinary Share | 13G/A | 0% | Dec 31, 2023 | 2y |
| Brookfield Oaktree Holdings, LLC | DUET DUET Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | DCTH Delcath Systems, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Sandia Investment Management LP | ANGX Angel Studios, Inc. | 13G | 5.39% | Dec 31, 2023 | 2y |
| Lynx1 Capital Management LP | CABA Cabaletta Bio, Inc. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| Marco Fregenal | FTHM Fathom Holdings Inc. | 13G/A | 7.3% | Dec 31, 2023 | 2y |
| Conifer Management, L.L.C. | RMNI Rimini Street, Inc. | 13G/A | 6.62% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | FRXB Forest Road Acquisition Corp. II | 13G/A | 0% | Dec 31, 2023 | 2y |
| Fort Baker Capital Management LP | LVRA Levere Holdings Corp. Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| Two Seas Capital LP | ESPR Esperion Therapeutics, Inc. | 13G/A | 6.8% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | BRO Brown & Brown, Inc. | 13G/A | 5% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | AP Ampco Pittsburgh Corp | 13G/A | 4.93% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | DXLG Destination XL Group, Inc. | 13G/A | 15.6% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | CTLT CATALENT, INC. | 13G/A | 6.2% | Dec 31, 2023 | 2y |
| Nathaniel Ru | SG Sweetgreen, Inc. | 13G/A | 5.83% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | BEEM Beam Global | 13G | 6.4% | Dec 31, 2023 | 2y |
| BlackRock Inc. | BATRA Atlanta Braves Holdings, Inc. | 13G | 7.1% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | FTI TechnipFMC plc | 13G | 8.3% | Dec 31, 2023 | 2y |
| EVENTIDE ASSET MANAGEMENT, LLC | MIRM Mirum Pharmaceuticals, Inc. | 13G/A | 5.78% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | KRTX Karuna Therapeutics, Inc. Common Stock | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | ANGX Angel Studios, Inc. | 13G | 8.38% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | REKR Rekor Systems, Inc. | 13G | 9.79% | Dec 31, 2023 | 2y |
| Lytton, Laurence W. | GYRE Gyre Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Steven J. Schwartz | CBNK Capital Bancorp Inc | 13G/A | 5.25% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | AEIS Advanced Energy Industries Inc | 13G/A | 6.68% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | RBC RBC Bearings INC | 13G/A | 7.1% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | TMCI Treace Medical Concepts, Inc. | 13G/A | 0.1% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | WINV WinVest Acquisition Corp. | 13G | 7.21% | Dec 31, 2023 | 2y |
| Jared Isaacman | FOUR Shift4 Payments, Inc. | 13G/A | 30.12% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | STI Solidion Technology Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| CANADA PENSION PLAN INVESTMENT BOARD | FUSN Fusion Pharmaceuticals Inc. Common Shares | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | MACA Moringa Acquisition Corp Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | CPAY Corpay, Inc. | 13G | 5.8% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | OBK Origin Bancorp, Inc. | 13G/A | 12.9% | Dec 31, 2023 | 2y |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | HUDA Hudson Acquisition I Corp. Common Stock | 13G | 8.89% | Dec 31, 2023 | 2y |
| Divisadero Street Capital Management, LP | LFMD LifeMD, Inc. | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| Alyeska Investment Group, L.P. | APLT Applied Therapeutics, Inc. Common Stock | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Morris Goldfarb | GIII G III Apparel Group Ltd | 13G/A | 10.2% | Dec 31, 2023 | 2y |